NEW YORK (GenomeWeb News) – Princeton, NJ-based drug development services company Covance announced yesterday that it has purchased an undisclosed minority stake in the proteomics-based pharmaceutical services company Caprion Proteomics.
Under the agreement, Covance will use Caprion as its exclusive proteomic discovery provider and will act as the exclusive contract research organization distributor for Caprion’s proteomic biomarker services.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.